Association of the CCR5Δ32 Mutant Genotype with Sickle Cell Disease in Egyptian Patients

References

• Power CA, Meyer A, Nemeth K, et al. Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J Biol Chem. 1995;270(33):19495–19500.
   PubMed Web of Science ®Google Scholar
• Pierce KL, Premont R, Lefkowitz RJ. Seven-transmembrane receptors. Nat Rev Mol Cell Biol. 2002;3(9):639–650.
   PubMed Web of Science ®Google Scholar
• Oppermann M. Chemokine receptor CCR5: insights into structure, function, and regulation. Cell Signal. 2004;16(11):1201–1210.
   PubMed Web of Science ®Google Scholar
• Griffith JW, Sokol CL, Luster AD. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol. 2014;32(1):659–702.
   PubMed Web of Science ®Google Scholar
• Alexander SPH, Mathie A, Peters JA. Guide to receptors and channels (GRAC). Br J Pharmacol. 2008;153(S2):S1.
   PubMed Web of Science ®Google Scholar
• Sudarshan R, Bassoni DL, Campbell JJ, et al. Biased agonism as a mechanism for differential signaling by chemokine receptors. J Biol Chem. 2013;288(49):35039–35048.
   PubMed Web of Science ®Google Scholar
• Jiao X, Velasco-Velázquez MA, Wang M, et al. CCR5 governs DNA damage repair and breast cancer stem cell expansion. Cancer Res. 2018;78(7):1657–1671.
   PubMed Web of Science ®Google Scholar
• Martin-Blondel G, Brassat D, Bauer J, et al. CCR5 blockade for neuroinflammatory diseases–beyond control of HIV. Nat Rev Neurol. 2016;12(2):95–105.
   PubMed Web of Science ®Google Scholar
• Libert F, Cochaux P, Beckman G, et al. The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe. Hum Mol Genet. 1998;7(3):399–406.
   PubMed Web of Science ®Google Scholar
• Navratilova Z. Polymorphisms in CCL2&CCL5 chemokines/chemokine receptors genes and their association with diseases. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2006;150(2):191–204.
   PubMedGoogle Scholar
• Attar R, Agachan B, Kuran SB, et al. Association of CCL2 and CCR2 gene variants with endometrial cancer in Turkish women. In Vivo. 2010;24(2):243–248.
   PubMed Web of Science ®Google Scholar
• Narter KF, Agachan B, Sozen S, et al. CCR2-64I is a risk factor for development of bladder cancer. Genet Mol Res. 2010;9(2):685–692.
   PubMed Web of Science ®Google Scholar
• Nascimento AF, Oliveira JS, Silva JC, Jr, et al. Haplotypes and polymorphism in the CCR5 gene in sickle cell disease. Genet Mol Res. 2017;16(2). doi:10.4238/gmr16029675.
   Web of Science ®Google Scholar
• Carrington M, Dean M, Martin MP, et al. Genetics of HIV infection: chemokine receptor CCR5polymorphisms and its consequences. Hum Mol Genet. 1999;8(10):1939–1945.
   PubMed Web of Science ®Google Scholar
• Chies JAB, Hutz MH. High frequency of the CCR5delta32 variant among individuals from an admixed 4 disease markers Brazilian population with sickle cell anemia. Braz J Med Biol Res. 2003;36(1):71–75.
   PubMed Web of Science ®Google Scholar
• Doodes PD, Cao Y, Hamel KM, et al. CCR5 is involved in resolution of inflammation in proteoglycan induced arthritis. Arthritis Rheum. 2009;60(10):2945–2953.
   PubMed Web of Science ®Google Scholar
• Zimmerman PA, Buckler-White A, Alkhatib G, et al. Inherited resistance to HIV-1 infection conferred by an inactivating mutation in CC chemokine receptor 5 - studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol Med. 1997;3(1):23–26.
   PubMed Web of Science ®Google Scholar
• Chan YH. Biostatistics 103: qualitative data - tests of independence. Singapore Med J. 2003;44(10):498–403.
   PubMedGoogle Scholar
• Chan YH. Biostatistics 202: logistic regression analysis. Singapore Med J. 2004;45(4):149–453.
   PubMedGoogle Scholar
• Jones KL, Maguire JJ, Davenport AP. Chemokine receptor CCR5: from AIDS to atherosclerosis. Br J Pharmacol. 2011;162(7):1453–1469.
   PubMed Web of Science ®Google Scholar
• Dorr P, Westby M, Dobbs S, et al. Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob Agents Chemother. 2005;49(11):4721–4732.
   PubMed Web of Science ®Google Scholar
• Pichenot M, Deuffic-Burban D, Cuzin L, et al. Efficacy of new antiretroviral drugs in treatment-experienced HIV-infected patients: a systematic review and meta-analysis of recent randomized controlled trials. HIV Med. 2012;13(3):148–155.
   PubMed Web of Science ®Google Scholar
• Karaali ZE, Sozen S, Yurdum M, et al. Effect of genetic variants of chemokine receptors on the development of myocardial infarction in Turkish population. Mol Biol Rep. 2010;37(7):3615–3619.
   PubMed Web of Science ®Google Scholar
• Zúñiga JA, Villarreal-Garza C, Flores E, et al. Biological relevance of the polymorphism in the CCR5 gene in refractory and non-refractory rheumatoid arthritis in Mexicans. Clin Exp Rheumatol. 2003;21(3):351–354.
   PubMed Web of Science ®Google Scholar
• Srivastava P, Helms PJ, Stewart D, et al. Association of CCR5 32 with reduced risk of childhood but not adult asthma. Thorax. 2003;58(3):222–226.
   PubMed Web of Science ®Google Scholar
• Andoka G, Thiloemba Moussoki J, et al. Evaluation of the incidence of glucose-6-phosphate dehydrogenase deficiency in children with sickle cell anemia in Brazzaville (Congo). Med Trop. 1988;48(3):249–251.
   PubMedGoogle Scholar
• Al-Riyami A, Ebrahim GJ. Genetic blood disorders survey in the Sultanate of Oman. J Trop Pediatr. 2003;49(1):11–20.
   Google Scholar
• Piel FB, Howes RE, Patil AP, et al. The distribution of Haemoglobin C and its prevalence in newborns in Africa. Sci Rep. 2013;3(1):1671–1678.
   PubMed Web of Science ®Google Scholar
• McPherson RA. Pincus MR, editor. Henry’s clinical diagnosis and management by laboratory methods. 21st ed. Philadephia (PA): Saunders Elsevier; 2007. p. 520–530.
   Google Scholar
• RKl A, Patel RK, Shah V, et al. Hydroxyurea in sickle cell disease: drug review. Indian J Hematol Blood Transfus. 2014;30(2):91–96.
   PubMed Web of Science ®Google Scholar
• Leikin SL, Gallagher D, Kinney TR, et al. Mortality in children and adolescents with sickle cell disease. Cooperative study of sickle cell disease. Pediatrics. 1989;84(3):500–508.
   PubMed Web of Science ®Google Scholar
• Odièvre MH, Bony V, Benkerrou M, et al. Modulation of erythroid adhesion receptor expression by hydroxyurea in children with sickle cell disease. Haematologica. 2008;93(4):502–510.
   PubMed Web of Science ®Google Scholar
• Gladwin MT, Shelhamer JH, Ognibene FP, et al. Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease. Br J Haematol. 2002;116(2):436–444.
   PubMed Web of Science ®Google Scholar
• Iversen AKN, Christiansen CB, Attermann J, et al. Limited protective effect of the CCR5Δ32/CCR5Δ32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virus. J Infect Dis. 2003;187(2):215–225.
   PubMed Web of Science ®Google Scholar
• Kato GJ, McGowan V, Machado RF, et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood. 2006;107(6):2279–2285.
   PubMed Web of Science ®Google Scholar
• Ferreira-Fernandes H, Santos ACC, Motta FJN, et al. Prevalence of CCR5-Δ32 and CCR2-V64I polymorphisms in a mixed population from northeastern Brazil. Genet Mol Res. 2015;14(4):11710–11718.
   PubMed Web of Science ®Google Scholar
• Vargas AE, Da Silva MAL, Silla L, et al. Polymorphisms of chemokine receptors and eNOSin Brazilian patients with sickle cell disease. Tissue Antigens. 2005;66(6):683–690.
   PubMedGoogle Scholar